Blood Product Supply

Completed

Conditions studied: COVID-19

In brief

Data about the links between Coronavirus disease 2019(COVID-19) and the safety of blood products during the pandemic is inadequate. During the COVID-19 pandemic, high volumes of patients receiving blood products due to post-terminal surgical complications depleted stores for the entire hospital, resulting in surgeons unable to acquire emergent blood products. Data from this study can be used to develop a policy on how to handle blood shortage issues during this and future pandemics. Also, this data can be used to determine future policies on use of blood products from COVID-19-positive donors.

Key facts

Study ID

NCT07490314

Run by

Methodist Health System

People needed

100

Starts

2020-03-01

Expected to finish

2025-06-25

Last updated by the study team

2026-03-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• >_18 years of age Surgical patients treated at Methodist Dallas Medical Center(MDMC)

You may not qualify if…

• <18 years of age Prisoners Pregnant women

Where it is running

• Methodist Dallas Medical Center- Clinical Research Institute — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.